Yahoo Web Search

Search results

    • AbbVie Completes Acquisition of Landos Biopharma

      The Longview News-Journal· 2 days ago

      With the completion of the acquisition, Landos is now part of AbbVie. Landos' lead investigational asset is NX-13, a first-in-class, oral NLRX1 agonist (a member of the NOD-like receptor family ...